rediff.com
e.g. Tata motors, Reliance MF, 500570
Aurobindo Pharma Ltd. - Research Center
524804 AUROPHARMA Group (A) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Quarterly results in brief
(Rs crore)
Dec' 24 Sep' 24 Jun' 24 Mar' 24 Dec' 23
Sales 2,916.63 2,824.59 2,460.09 2,894.03 2,692.03
Operating profit 713.15 720.88 498.93 774.79 481.69
Interest 66.19 51.63 51.13 53.07 61.25
Gross profit 701.22 791.91 513.12 844.69 751.57
EPS (Rs) 8.13 9.25 5.62 9.88 10.65
Quarterly  results in details
Dec' 24 Sep' 24 Jun' 24 Mar' 24 Dec' 23
Other income 54.26 122.66 65.32 122.97 331.13
Stock adjustment -61.37 -31.25 -35.56 -13.10 -59.76
Raw material 1,506.59 1,424.74 1,318.18 1,401.56 1,465.93
Power and fuel - - - - -
Employee expenses 265.15 265.48 259.33 248.91 248.08
Excise - - - - -
Admin and selling expenses - - - - -
Research and development expenses - - - - -
Expenses capitalised - - - - -
Other expenses 493.11 444.74 419.21 481.87 556.09
Provisions made - - - - -
Depreciation 68.28 68.16 66.88 64.81 64.35
Taxation 160.89 186.22 117.20 201.21 63.44
Net profit / loss 472.05 537.53 329.04 578.67 623.78
Extra ordinary item - - - - -
Prior year adjustments - - - - -
Equity capital 58.08 58.08 58.59 58.59 58.59
Equity dividend rate - - - - -
Agg.of non-prom. shares (Lacs) - - - - -
Agg.of non promotoholding (%) - - - - -
OPM (%) 24.45 25.52 20.28 26.77 17.89
GPM (%) 23.60 26.87 20.32 28.00 24.86
NPM (%) 15.89 18.24 13.03 19.18 20.63
Close
Add Aurobindo Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Aurobindo Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close